The global molecular oncology market is projected to reach US$ 7.4 billion by 2034, driven by advancements in cancer research, personalized medicine, and the increasing prevalence of various cancer types. Key players in the market are focusing on developing innovative products and technologies to address the growing demand for molecular diagnostics and targeted therapies.